Metabolic sequelae of cancers (excluding bone marrow transplantation)

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 2, Issue 4, 1999, Pages 339-344

  Body, Jean Jacques ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYTOKINE; HORMONE;

ANOREXIA; BONE MARROW TRANSPLANTATION; CACHEXIA; DRUG ANTAGONISM; ENTERIC FEEDING; HUMAN; METABOLISM; NEOPLASM; PARENTERAL NUTRITION; REVIEW;

ADRENAL CORTEX HORMONES; ANOREXIA; BONE MARROW TRANSPLANTATION; CACHEXIA; CYTOKINES; ENTERAL NUTRITION; HORMONES; HUMANS; NEOPLASMS; PARENTERAL NUTRITION;

EID: 0033160869     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-199907000-00016     Document Type: Article

References (46)

1. Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 1980; 69:491-497.
2. Body JJ, Lossignol D, Ronson A. The concept of rehabilitation of cancer patients. Curr Opin Oncol 1997; 9:332-340.
3. Hammerlid E, Wirblad B, Sandin C, Mercke C, Edström S, Kaasa S, et al. Malnutrition and food intake in relation to quality of life in head and neck cancer patients. Head Neck 1998; 20:540-548.
4. Tchekmedyian NS. Pharmacoeconomics of nutritional support in cancer. Semin Oncol 1998; 25:62-69.
5. Murry DJ, Riva L, Poplack DG. Impact of nutrition on pharmacokinetics of anti-neoplastic agents. Int J Cancer 1998; Suppl 11:48-51.
6. Branda RF, Nigels E, Lafayette AR, Hacker M. Nutritional folate status influences the efficacy and toxicity of chemotherapy in rats. Blood 1998; 92:2471-2476.
7. Tisdale MJ. Cancer cachexia: metabolic alterations and clinical manifestations. Nutrition 1997; 13:1-7.
8. Brennan MF. Uncomplicated starvation versus cancer cachexia. Cancer Res 1997; 37:2359-2364.
9. Ovesen L. Anorexia in patients with cancer with special references on its association with early changes in food intake behaviour; chemotherapeutic treatment and adjuvant enteral nutrition. Intern J Oncol 1994; 5:889-899.
10. Torosian MH, Donoway RB. Total parenteral nutrition and tumor metastasis. Surgery 1991; 109:597-601.
11. Dworzak F, Ferrari P, Gavazzi C, Maiorana C, Bozzetti F. Effects of cachexia due to cancer on whole body and skeletal muscle protein turnover. Cancer 1998; 82:42-48.
12. Fearon KCH, Falconer JS, Slater C, McMillan DC, Ross JA, Preston T. Albumin synthesis rates are not decreased in hypoalbuminemic cachectic cancer patients with an ongoing acute-phase protein response. Ann Surg 1998; 227:249-254.
13. Baro L, Hermoso JC, Nunez MC, Jimenez-Rios JA, Gil A. Abnormalities in plasma and red blood cell fatty acid profiles of patients with colorectal cancer. Br J Cancer 1998; 77:1978-1983.
14. De Blaauw I, Deutz NEP, Von Meyenfeldt MF. Metabolic changes in cancer cachexia - first of two parts. Clin Nutr 1997; 16:169-176.
15. De Blaauw I, Deutz NEP, Von Meyenfeldt MF. Metabolic changes of cancer cachexia - second of two parts. Clin Nutr 1997; 16:223-228.
16. Hyltander A, Drott C, Körner U, Sandström R, Lundholm K. Elevated energy expenditure in cancer patients with solid tumours. Eur J Cancer 1991; 27:9-15.
17. Jebb SA, Osborne RJ, Dixon AK, Bleehen NM, Elia M. Measurements of resting energy expenditure and body composition before and after treatment of small cell lung cancer. Ann Oncol 1994; 5:915-919.
18. Usuki K, Okazuki R, Iki S, Muramatsu M, Yamaguchi Y, Totsuka Y, Urabe A. Serum leptin levels during cancer chemotherapy. Ann Hematol 1998; 77:191-192.
19. Takahashi N, Waelput W, Guisez Y. Leptin is an endogenous protective protein against the toxicity exerted by tumor necrosis factor. J Exp Med 1999; 189:207-212.
20. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340:448-454.
21. Gelin J, Moldawer LL, Lönnroth C, Sherry B, Chizzonite R, Lundholm K. Role of endogenous tumor necrosis factor α and interleukin-1 for experimental tumor growth and the development of cancer cachexia. Cancer Res 1991; 51:415-421.
22. Janik JE, Curti BD, Considine RV, Rager HC, Powers GC, Alvord WG, et al. Interleukin-1-α increases serum leptin concentrations in humans. J Clin Endocrinol Metab 1997; 82:3084-3086.
23. Mantovani G, Maccio A, Lai P, Massa E, Ghiani M, Santona MC. Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate. Semin Oncol 1998; 25 (suppl 6):45-52.
24. Zinman B, Hanley AJG, Harris SB, Kwan J, Fantus IG. Circulating tumor necrosis factor-α concentrations in a native Canadian population with high rates of type 2 diabetes mellitus. J Clin Endocrinol Metab 1999; 84:272-278.
25. Klein S, Kinney J, Jeejeebhoy K, Alpers D, Hellerstein M, Murray M, et al. Nutrition support in clinical practice: review of published data and recommendations for future research directions. Clin Nutr 1997; 16:193-218.
26. Sikora SS, Ribeiro U, Kane III JM, Landreneau RJ, Lembersky B, Posner MC. Role of nutrition support during induction chemoradiation therapy in esophageal cancer. J Parenter Enter Nutr 1998; 22:18-21.
27. Klein GL, Rogers JZ, Friedman J, Jensen GL. A multidisciplinary approach to home enteral nutrution. Nutr Clin Pract 1998; 13:157-162.
28. Van Eys J. Benefits of nutritional intervention on nutritional status, quality of life and survival. Int J Cancer 1998; Suppl 11:66-68.
29. Andrassy RJ, Chwals WJ. Nutritional support of the pediatric oncology patient. Nutrition 1998; 14:124-129.
30. Mercadante S. Parenteral versus enteral nutrition in cancer patients: indications and practice. Support Care Cancer 1998; 6:85-93.
31. Lee JH, Machtay M, Unger LD, Weinstein GS, Weber RS, Chalian AA, Rosenthal DI. Prophylactic gastrostomy tubes in patients undergoing intensive irradiation of cancer of the head and neck. Arch Otolaryngol Head Neck Surg 1998; 124:871-875.
32. Craighead PS, Young S. Phase II study assessing the feasibility of using elemental supplements to reduce acute enteritis in patients receiving radical pelvic radiotherapy. Am J Clin Oncol 1998; 21:573-578.
33. Dagnelie PC, Bell JD, Williams SCR, Bates TE, Abel PD, Foster CS. Effect of fish oil on cancer cachexia and host liver metabolism in rats with prostate tumors. Lipids 1994; 29:195-203.
34. Gogos CA, Ginopoulos P, Salsa B, Apostolidou E, Zoumbos NC, Kalfarentzos F. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalised malignancy. Cancer 1998; 82:395-402.
35. Griffini P, Fehres O, Klieverik L, Vogels IMC, Tigchelaar W, Smorenburg SM, Van Noorden CJF. Dietary Ω-3 polyunsaturated fatty acids promote colon carcinoma metastasis in rat liver. Cancer Res 1998; 58:3312-3319.
36. Ottery FD, Walsh D, Strawford A. Pharmacologic management of anorexia/ cachexia. Semin Oncol 1998; 25 (suppl 6):35-44.
37. Bunn Jr PA. Cancer and acquired immunodeficiency syndrome wasting syndromes: current and future therapies. Semin Oncol 1998; 25 (Suppl 6):1-3.
38. McNurlan MA, Garlic PJ, Frost RA, Decristofaro KA, Lang CH, Steigbigel RT, et al. Albumin synthesis and bone collagen formation in human immunodeficiency virus-positive subjects: differential effects of growth hormone administration. J Clin Endocrinol Metab 1998; 83:3050-3055.
39. Muurahainen N, Mulligan K. Clinical trials update in human immunodeficiency virus wasting. Semin Oncol 1998; 25 (suppl 6):104-111.
40. Bhasin S, Storer TW, Asbel-Sethi N, Kilbourne A, Hays R, Sinha-Hikim I, et al. Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels. J Clin Endocrinol Metab 1998; 83:3155-3162.
41. Zachwieja JJ, Smith SR, Lovejoy JC, Rood JC, Windhauser MM, Bray GA. Testosterone administration preserves protein balance but not muscle strength during 28 days of bed rest. J Clin Endocrinol Metab 1999; 84:207-212.
42. Lissoni P, Paolorossi F, Tancini G, Barni S, Ardizzoia A, Brivio F, et al. Is there a role for melatonin in the treatment of neoplastic cachexia? Eur J Cancer 1996; 32A:1340-1343.
43. Gagnon B, Bruera E. A review of the drug treatment of cachexia associated with cancer. Drugs 1998; 55:675-688.
44. Goldberg RM, Loprinzi CL, Mailliard JA, O'Fallon JR, Krook JE, Ghosh C, et al. Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial. J Clin Oncol 1995; 13:2856-2859.
45. Haslett PAJ. Anticytokine approaches to the treatment of anorexia and cachexia. Semin Oncol 1998; 25 (suppl 6):53-57.
46. McMillan DC, O'Gorman P, Fearon KCH, McArdle CS. A pilot study of cachexia in gastrointestinal cancer patients. Br J Cancer 1997; 76:788-790.